Sponsor or institution
Clinical trials and research at Instituto Mexicano del Seguro Social
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Instituto Mexicano del Seguro Social that are recruiting, in Mexico. By phase: Phase 4 (5), Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
Darunavir/ritonavir plus lamivudine vs darunavir/ritonavir plus tenofovir alafenamide/emtricitabine in virologically suppressed adults with HIV
This trial tests whether a two-drug regimen (darunavir/cobicistat plus lamivudine) works as well as a three-drug regimen (darunavir/cobicistat plus TAF/FTC) in adults with HIV who have stable viral suppression.
-
Capsaicin oral film to stimulate the sphenopalatine ganglion after acute ischemic stroke
This trial will test whether a dissolvable capsaicin oral film is safe and tolerable when given within 24 hours to adults with acute ischemic stroke.
-
Epicardial fat CT in patients after heart attack
This trial will test whether dapagliflozin or semaglutide reduces epicardial (around-the-heart) fat over 12 months in adults hospitalized with ST-elevation or non‑ST‑elevation myocardial infarction.
-
Switching to a two-drug dolutegravir/lamivudine regimen versus staying on three-drug therapy for people with suppressed HIV
This trial will test whether switching to a two-drug regimen (dolutegravir/lamivudine) keeps viral suppression and reduces metabolic and tolerability problems in adults with HIV who are already virologically suppressed on three-drug therapy.
-
Doravirine/TDF/3TC versus Bictegravir/FTC/TAF for adults with HIV who are overweight or obese
This trial will test whether a doravirine-based HIV pill or a bictegravir-based HIV pill leads to less weight gain in adults with HIV who are overweight or obese starting antiretroviral therapy.
-
Lidocaine plus dexmedetomidine during laparoscopic bariatric surgery to reduce pain, inflammation, and oxidative stress
This trial will try giving an intravenous combination of lidocaine and dexmedetomidine during laparoscopic bariatric surgery in adults with obesity to see if it lowers pain, inflammation, and oxidative stress after surgery.
-
DTG/3TC versus BIC/TAF/FTC as first-line HIV treatment for people new to antiretrovirals
This trial will test whether DTG/3TC gives similar viral control but less weight gain and metabolic side effects than BIC/TAF/FTC in adults newly starting HIV treatment.
-
Using indocyanine green to map blood flow during revisional bariatric surgery
This test will see if the low guideline dose of indocyanine green or a higher dose gives clearer blood-vessel imaging during revisional bariatric surgery for people with BMI ≥30.
-
Comparing two HIV treatment regimens in men with suppressed viral loads
This study is testing if a new combination of HIV medications can work just as well as the standard treatment for men who have their virus under control.
Quick answers
How many clinical trials run by Instituto Mexicano del Seguro Social are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Mexico. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 5, Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.